In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report).

In a report released today, Matt Miksic from Barclays reiterated a Buy rating on Medtronic (MDT – Research Report), with a price target ...

Analysts on Wall Street project that Medtronic (MDT) will announce quarterly earnings of $1.24 per share in its forthcoming report, representing a decline of 0.8% year over year. Revenues are ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

A Beverly Hills surgeon is suing Medtronic claiming patent infringement of her hernia repair mesh product. It's the latest in ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Consumers saw price relief at the gas pump and grocery store. But housing inflation and other categories, such as car ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

The latest trading session saw Medtronic (MDT) ending at $87.72, denoting a -0.45% adjustment from its last day's close. The stock's change was less than the S&P 500's daily gain of 0.38%. Meanwhile, ...

"Rising Chronic Disease Cases and Advancements in Medical Technology Drive Rapid Growth in the Infusion Pump Market" BOSTON, ...